The AACR Annual Meeting highlights the best and latest findings in all major areas of cancer research. The theme of the AACR Annual Meeting 2012, "Accelerating Science: Concept to Clinic," reflects this amazing progress and emphasizes the synergy between basic, clinical and translational research that will continue to lead to effective cancer therapies and prevention strategies.
Six press conferences were held during the meeting:
"Late-breaking Clinical Trials," Saturday, March 31, hosted by José Baselga, M.D., Ph.D., associate director and chief of hematology/oncology at the Massachusetts General Hospital Cancer Center in Boston, Mass.
"Personalized Medicine: Late-breaking Science From AACR Journals," Saturday, March 31, hosted by Lewis C. Cantley, Ph.D., director of the Cancer Center at Beth Israel Deaconess Medical Center in Boston, Mass.
"Breast and Gynecological Cancers," Sunday, April 1, hosted by Worta McCaskill-Stevens, M.D., head of breast cancer prevention at the National Cancer Institute in Rockville, Md.
Stand Up To Cancer hosted a press event Sunday, April 1, to announce the formation of the Stand Up To Cancer-Prostate Cancer Foundation Dream Team: Precision Therapy of Advanced Prostate Cancer and provide scientific updates from previous grant recipients.
"Vaccines and Immunotherapy," Monday, April 2, hosted by Olivera Finn, Ph.D., chair of the department of immunology at the University of Pittsburgh School of Medicine in Pittsburgh, Pa.
"Whole Genome Sequencing," Monday, April 2, hosted by Bert Vogelstein, M.D., the Clayton professor of oncology at the Johns Hopkins Kimmel Cancer Center, co-director of Hopkins' Ludwig Center for Cancer Biology Research in Baltimore, Md., and investigator at the Howard Hughes Medical Institute in Chevy Chase, Md.